Maija Hollmén

11PUBLICATIONS
58CO-AUTHORS
Molecular targetsPredictive and prognostic markersMechanobiologyGene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 27, 2026
Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

|Nov 17, 2025
Breast cancer remodels lymphatics in sentinel lymph nodes.

Dominik Eichin, Diana Lehotina, Anni Kauko

|May 16, 2025
Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment.

Jenna H Rannikko, Rita Turpin, Pia Boström

|Dec 31, 2024
Anti-CTLA4 treatment reduces lymphedema risk potentially through a systemic expansion of the FOXP3+ Treg population.

Stefan Wolf, Matiar Madanchi, Patrick Turko

|Jun 03, 2024
Clinical landscape of macrophage-reprogramming cancer immunotherapies.

Jenna H Rannikko, Maija Hollmén

|Nov 03, 2023
Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments.

Jenna H Rannikko, Petri Bono, Johanna Hynninen

Pageof 2

Frequent Collaborators

5 joint publications

Jenna H Rannikko

3 joint publications

Akira Takeda

2 joint publications

Tero Aittokallio

2 joint publications

Sirpa Jalkanen